Digenic Alport Syndrome

Digenic Alport syndrome refers to the inheritance of pathogenic variants in COL4A5 plus COL4A3 or COL4A4 or in COL4A3 plus COL4A4. Where digenic Alport syndrome includes a pathogenic COL4A5 variant, the consequences depend on the sex of the affected individual, COL4A5 variant ?severity,? and the nature of the COL4A3 or COL4A4 change. A man with a pathogenic COL4A5 variant has all his collagen IV ?3?4?5-heterotrimers affected, and an additional COL4A3 or COL4A4 variant may not worsen disease. A woman with a pathogenic COL4A5 variant has on average 50% of her heterotrimers affected, which is increased to 75% with a further COL4A3 or COL4A4 variant and associated with a higher risk of proteinuria. In digenic Alport syndrome with pathogenic COL4A3 and COL4A4 variants, 75% of the heterotrimers are affected. The COL4A3 and COL4A4 genes occur head-to-head on chromosome 2, and inheritance is autosomal dominant when both variants affect the same chromosome (in cis) or recessive when they affect different chromosomes (in trans). This form of digenic disease results in increased proteinuria and a median age of kidney failure intermediate between autosomal dominant and autosomal recessive Alport syndrome. Previous guidelines have suggested that all pathogenic or likely pathogenic digenic variants should be identified and reported. Affected family members should be identified, treated, and discouraged from kidney donation. Inheritance within a family is easier to predict if the two variants are considered independently and if COL4A3 and COL4A4 variants are known to be inherited on the same or different chromosomes.

Automated summary

Digenic Alport syndrome refers to the inheritance of pathogenic variants in COL4A5 plus COL4A3 or COL4A4, or in COL4A3 plus COL4A4. The consequences depend on sex, severity of COL4A5 variant, and nature of COL4A3 or COL4A4 change. In males with COL4A5 variant, all collagen IV ?3?4?5-heterotrimers are affected. In females with COL4A5 variant, on average 50% of heterotrimers are affected, increased to 75% with additional COL4A3 or COL4A4 variant. In digenic Alport syndrome with COL4A3 and COL4A4 variants, 75% of heterotrimers are affected. Inheritance is autosomal dominant or recessive based on variants' effect on the same or different chromosomes. This form of digenic disease results in increased proteinuria and median age of kidney failure intermediate between autosomal dominant and autosomal recessive Alport syndrome. Previous guidelines recommend identification and reporting of all pathogenic or likely pathogenic digenic variants, as well as identification and treatment of affected family members.